Bixiye
P63-17 New Drug-Related PA with Quantity Limit Criteria: Otezla (apremilast)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 3061 - 3070 ee natiijooyinka 3273
Bixiye
P61-17 FQHC/RHC Clinics Providing Interpreter Services for MHCP Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2017
Bixiye
QP34-17 New Pre-Authorization Form for Immunoglobulin Therapy
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2017
Bixiye
P59-17 Government Programs Subscribers Prior Authorization Requirement for Spinal Fusion: Lumbar
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2017
Bixiye
P60-17 2018 Renewal Changes Summary for Institutional Providers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2017
Bixiye
P19R1-17 New Remittance Code: OA-45 for Purchased/Referred (PRC)-Eligible Subscribers
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017
Bixiye
P58-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Topical Doxepin
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017
Bixiye
P57-17 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017
Bixiye
QP33-17 ICD-10 Grouper Updates
Taariikhda uu dhaqangalayo barnaamijka: Okt 17, 2017
Bixiye
P56-17 Implementation of a Medical Drug Exclusions List
Taariikhda uu dhaqangalayo barnaamijka: Okt 16, 2017